Date

Apr 25, 2024

Attendees

Present

Name

Organization

-

Nancy Cornish

CDC

X

Manjula Gama-Ralalage

CDC

-

Riki Merrick

APHL

X

Christina Gallegos

APHL

X

Amy Liu

Inductive Health / APHL

 

Raj Dash

Duke / CAP

 X

John Snyder

National Library of Medicine (SNOMED CT)

 

Andrea Pitkus

UW

 X

Kathy Walsh

Labcorp

 

Rob Hausam

Hausam Consulting

 

Doug York

APHL

 

Pam Banning

 3M

Discussion topics

Topic

Discussed?

Notes

Updates


Riki and Nancy OOO. Canceled call early.

Updated group about progress on Sandy Jones meeting regarding reporting biomarkers to cancer registries

  • Nancy emailed Sandy Jones on April 11th. Sandy will attend our LabMCoP call on May 2nd to discuss challenges and how the LabMCoP team could potentially assist cancer registries

Upcoming OOO

Yes

Previous Action Items

 

  • Nancy Follow up:

    • EDTA Stopper top

    • Contact United Network for Organ Sharing for input on donor terms (pre-coordinated or not?) = Contact - UNOS

      • Nancy reached out to Scott A. Brubaker (he/him/his) at the FDA. He suggested to reach out to UNOS and complete an online form: https://unos.org/contact/

      • https://www.isbt128.org/technical-documents

      • Scott’s response: “When the SNOMED representative referred to the existence of “donor codes,” they might be referring to the ISBT-128 coding standard that’s managed by ICCBBA. Please see their website: ISBT 128 | ICCBBA, and navigate to view their technical documents: ISBT 128 | ICCBBA | Technical DocumentsFDA’s regulations for human cells, tissues, and cellular and tissue-based products (HCT/Ps) in 21 CFR part 1271 require assignment of a “distinct identification code” to facilitate tracking HCT/Ps (see 21 CFR 1271.290(c)) but I don’t believe this is relevant to your question.”

      • Might be a topic for SNOMED International

      • We may need to reach out to laboratories/industry to see if the donor codes are needed (we need to show that these codes are needed.)

  • Amy follow up - check if she has all of these

    • nasal sinus fluid definition

    • surgical insertion site peritonealDialysisTunnelSite

    • surgical insertion site peritonealDialysisSite

  • Riki’s Follow up:

Specimen CMT - review of terms with questions

 


CALL ADJOURNED

Yes

1:?? PM ET

Specimen CMT pilot implementers

No

Specimen CMT - Hosting Options

 No

  • How can we publish the content in the dB?

    • Allow access somehow to query the dB

    • as access or excel or csv

    • Using FHIR conceptMap similar to Conceptmap-example-specimen-type - FHIR v6.0.0-cibuild - based on this profile: ConceptMap - FHIR v6.0.0-cibuild

    • to ask Eric if he still has that or how he built it:

    • ANSWER FROM ERIC:

      • if you look in the xml source Conceptmap-example-specimen-type.xml - FHIR v6.0.0-cibuild . you can see how it is mapped. 

      • I am not sure if you mean the table rendering or creating the concept map from a spreadsheet or CSV file.  The FHIR build tool did the table rendering for that mapping, I think I entered the data by hand, or Grahame did it. It would not be hard to create a script to create a concept map from an excel or csv file if needed.  The table needs to be large enough to make it worthwhile though. you could even create formula cells in the spreadsheet to generate the XML or json for each item. and then copy to a text editor and append to the Metadata fields.

      • There will be a call Clinical Architecture on May 3rd to discuss moving specimen CMT to Symedical

      • Manjula will take a look at the concept map

Specimen CMT - education

 No

 

Specimen CMT - tracking implementation impact

  • Setting baseline

  • Define metrics

 No

 

Specimen CMT - Compare to NHS Medical Terminology testing

 No

 

LOINC to SNOMED CT mapping

 No

 

Reporting Biomarkers to Cancer registries

 No

National Program of Cancer Registries (NPCR) | CDC

Sandy Jones will put together a one-pager - Nancy will reach out

Future projects for this call after CMT

 No

  • In general the call is intended as a forum for ANY messaging related issues to work out.

  • In the past we have

    • reviewed containers re-vive that - and how does that interact with devices (UDI identification?)

    • review code systems around additives (HL70371 and SCT substance and product hierarchies)

    • started work on cross-mapping between HL7 method codes and SNOMED CT procedure / technique concepts

      • American College of Surgeons is working on procedure protocol and synoptic data elements / surgical synoptic reports - we could work with them together on that

    • Look at other HL7 tables that we would want to migrate SCT (i.e., Specimen Condition table, etc.)

Recording:

From Chat:

John Snyder (NLM):


John Snyder (NLM): Scott A. Brubaker (he/him/his)
John Snyder (NLM): Scott A. Brubaker (he/him/his) Director, Division of Human Tissues Office of Cellular Therapy and Human Tissue CMC Office of Therapeutic Products FDA | Center for Biologics Evaluation and Research10903 New Hampshire Avenue | Silver Spring, MD 20993scott.brubaker@fda.hhs.gov

Action items



Type your action, use '@' to assign to someone.

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.



  1. Add a decision…

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.

Create from Template